Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 327,000 | 106,000 | 389,000 | 174,000 | 208,000 |
| Other Working Capital | -604,000 | 5,309,000 | -679,000 | -85,000 | -558,000 |
| Other Operating Activity | 1,421,000 | -2,424,000 | 2,057,000 | 1,147,000 | 853,000 |
| Operating Cash Flow | $1,144,000 | $2,991,000 | $1,767,000 | $1,236,000 | $503,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -247,000 | -513,000 | -331,000 | -314,000 | -287,000 |
| Net Acquisitions | 180,000 | 484,000 | 80,000 | 96,000 | -68,000 |
| Purchase Sale Intangibles | -156,000 | -164,000 | 60,000 | -92,000 | -330,000 |
| Other Investing Activity | 24,000 | 16,000 | 241,000 | 118,000 | 18,000 |
| Investing Cash Flow | $-199,000 | $-174,000 | $-174,000 | $-254,000 | $-667,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -528,000 | -311,000 | -740,000 | 1,400,000 | -201,000 |
| Common Stock Issued | 32,000 | 14,000 | 48,000 | 18,000 | 9,000 |
| Common Stock Repurchased | -61,000 | -4,000 | -12,000 | -6,000 | -52,000 |
| Dividend Paid | -925,000 | -925,000 | -923,000 | -2,083,000 | -919,000 |
| Other Financing Activity | -27,000 | -717,000 | -338,000 | -500,000 | -150,000 |
| Financing Cash Flow | $-1,509,000 | $-1,943,000 | $-1,965,000 | $-1,171,000 | $-1,313,000 |
| Exchange Rate Effect | 11,000 | 80,000 | 59,000 | 180,000 | -36,000 |
| Beginning Cash Position | 4,605,000 | 3,651,000 | 3,964,000 | 3,973,000 | 5,486,000 |
| End Cash Position | 4,052,000 | 4,605,000 | 3,651,000 | 3,964,000 | 3,973,000 |
| Net Cash Flow | $-564,000 | $874,000 | $-372,000 | $-189,000 | $-1,477,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,144,000 | 2,991,000 | 1,767,000 | 1,236,000 | 503,000 |
| Capital Expenditure | -416,000 | -761,000 | -495,000 | -477,000 | -619,000 |
| Free Cash Flow | 728,000 | 2,230,000 | 1,272,000 | 759,000 | -116,000 |